Noninvasive dopamine determination by reversed phase HPLC in the medium of free-floating roller tube cultures of rat fetal ventral mesencephalon: A tool to assess dopaminergic tissue prior to grafting

Brain Research Bulletin

Volumn 41, Issue 3, 1996, Pages 143-150

  Studer, L ^a   Psylla, M ^b   Buhler B ^a   Evtouchenko, L ^a   Vouga, C M ^a   Leenders, K L ^b   Seiler, R W ^a   Spenger, C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

Catecholamine; Fetal tissue; Functional assessment; Substantia nigra; Tissue culture

Indexed keywords

DOPAMINE;

ANIMAL TISSUE; ARTICLE; CELL VIABILITY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; EMBRYO; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NERVE TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 0029837256     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(96)00114-1     Document Type: Article

References (40)

1. 1. Abercrombie, M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:239-247; 1946.
2. 2. Altman, J.; Bayer, S. A. Development of the brain stem in the rat. V. Thymidine-radiographic study of the time of origin of neurons in the midbrain tegmentum. J. Comp. Neurol. 198:677-716; 1981.
3. 3. Björklund, A.; Schmidt, R. H.; Stenevi, U. Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res. 212:39-45; 1980.
4. 4. Björklund, A.; Dunnett, S. B. Neural transplantation in adult rats. In: Dunnett, S. B.; Björklund, A. eds. Neural transplantation: A practical approach. New York: Oxford University Press; 1992:57-78.
5. 5. Brundin, P.; Barbin, G.; Strecker, R. E.; Isacson, O.; Prochiantz, A.; Björklund, A. Survival and function of dissociated dopamine neurons grafted at different developmental stages or after being cultured in vitro. Dev. Brain Res. 39:233-243; 1988.
6. 6. Brundin, P.; Duan, W.-M.; Sauer, H. Neural transplantation in Parkinson's disease. In: Dunnett, S. B.; Björklund, A. eds. Functional neural transplantation. New York: Raven Press Ltd.; 1994:9-46.
7. 7. Brundin, P.; Isacson, O.; Björklund, A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331:251-259; 1985.
8. 8. Dunnett, S. B.; Björklund, A. Staging and dissection of rat embryos. In: Dunnett, S. B.; Björklund, A. eds. Neural transplantation: A practical approach. Oxford: Oxford University Press; 1992:1-19.
9. 9. Fawcett, J. E.; Barker, R. A.; Dunnett, S. B. Dopaminergic survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp. Brain Res. 106:275-282; 1995.
10. 10. Freed, C. R.; Breeze, R. E.; Rosenberg, N. L.; Schneck, S. A. Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease replacing failed nerve terminals. Adv. Neurol. 60:721-728; 1993.
11. 11. Freed, C. R.; Breeze, R. E.; Rosenberg, N. L.; Schneck. S. A.; Kriek, E.; Qi, J.; Lone, T.; Zhang, Y.; Snyder, J. A.; Wells, T. H.; Olson Ramig, L.; Thompson, L.; Mazziotta, J. C.; Huang, S. C.; Grafton, S. T.; Brooks, D.; Sawle, G. V.; Schroter, G.; Ansari, A. A. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327:1549-1555; 1992.
12. 12. Freed, C. R.; Breeze, R. E.; Rosenberg, N. L.; Schneck, S. A.; Wells, T.; Barrett, J. N.; Grafton, S. T.; Mazziotta, J. C.; Eidelberg, D.; Rottenberg, D. A. Therapeutic effects of human fetal dopamine cells transplanted in a patient with Parkinson's disease. Prog. Brain. Res. 82:715-721; 1990.
13. 13. Freeman, T. B.; Olanow, C. W.; Hauser, R. A.; Nauert, G. M.; Smith, D. A.; Borlongan, C. V.; Sanberg, P. R.; Holt, D. A.; Kordower, J. H.; Vingerhoets, J. G.; Snow, B. J.; Calne, D.; Gauger, L. I. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38:379-388; 1995.
14. 14. Freeman, T. B.; Sanberg, P. R.; Nauert, G. M.; Boss, B. D.; Spector, D.; Olanow, C. W.; Kordower, J. H. The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant. 4:141-154; 1995.
15. 15. Gähwiler, B. H. Organotypic monolayer cultures of nervous tissue. J. Neurosci. Methods 4:329-342; 1981.
16. 16. Gähwiler, B. H. Slice cultures of cerebellar, hippocampal and hypothalamic tissue. Experientia 40:235-243; 1984.
17. 17. Gueritaud, J. P.; Seyfritz, N. An organotypic Co-culture of embryonic rat brainstem and tongue or skeletal muscle. Eur. J. Neurosci. 4:616-627; 1992.
18. 18. Guyenet, P. G.; Crane, J. K. Nondopaminergic nigrostriatal pathway. Brain Res. 213:291-305; 1981.
19. 19. Hudson, J.; Granholm, A. C.; Gerhardt, G. A.; Henry, M. A.; Huffman, A.; Biddle, P.; Leela, N. S.; Mackerlova, L.; Lile, J. D.; Collins, F. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36:425-432; 1995.
20. 20. Hyman, C.; Juhasz, M.; Jackson, C.; Wright, P.; Ip, N. Y.; Lindsay, R. M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:335-347; 1994.
21. 21. Kalsbeek, A.; Voorn, P.; Buijs, R. M. Development of dopamine-containing systems in the CNS. In: Björklund, A.; Hökfelt, T.; Tohyama, M. eds. Ontogeny of transmitters and peptides in the CNS. Amsterdam: Elsevier Science Publishers; 1992:63-112.
22. 22. Kontur, P. J.; Leranth, C.; Redmond, D. E., Jr.; Roth, R. H.; Robbins, R. J. Tyrosine hydroxylase immunoreactivity and monoamine and metabolite levels in cryopreserved human fetal ventral mesencephalon. Exp. Neurol. 121:172-180; 1993.
23. 23. Lauder, J. M.; Bloom, F. E. Ontogeny of monoamine neurons in the locus coeruleus, Raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J. Comp. Neurol. 155:469-481; 1974.
24. 24. Lindsay, R. M.; Altar, C. A.; Cedarbaum, J. M.; Hyman, C.; Wiegand, S. J. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp. Neurol. 124:103-118; 1993.
25. 25. Lindvall, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustavii, B.; Frackowiak, R.; Leenders, K. L.; Sawle, G.; Rothwell, J. C.; Marsden, C. D. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577; 1990.
26. 26. Lindvall, O.; Widner, H.; Rehncrona, S.; Brundin, P.; Odin, P.; Gustavii, B.; Frackowiak, R.; Leenders, K. L.; Sawle, G.; Rothwell, J. C.; Björklund, A.; Marsden, C. D. Transplantation of fetal dopamine neurons in Parkinson's disease: One year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31 (2):155-165; 1992.
27. 27. Marchand, R.; Poirier, L. J. Isthmic origin of neurons of the rat substantia nigra. Neuroscience 9:373-381; 1983.
28. 28. Olson, L.; Seiger, A. Early prenatal ontogeny of central monoamine neurons in the rat: fluorescence histochemical observations. Z. Anat. Entwicklungsgesch. 137:301-316; 1972.
29. 29. Ostergaard, K.; Schou, J. P.; Zimmer, J. Rat ventral mesencephalon grown as organotypic slice cultures and co-cultured with striatum, hippocampus, and cerebellum. Exp. Brain Res. 82:547-565; 1990.
30. 30. Simonds, G. R.; Freed, W. J. Effects of intraventricular substantia nigra allografts as a function of donor age. Brain Res. 530:12-19; 1990.
31. 31. Sorensen, J. C.; Ostergaard, K.; Zimmer, J. Grafting of dopaminergic ventral mesencephalic slice cultures to the striatum of adult rats. Exp. Neurol. 127:199-206; 1994.
32. 32. Specht, L. A.; Pickel, V. M.; Joh, T. H.; Reis, D. J. Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. I. Early ontogeny. J. Comp. Neurol. 199:233-253; 1981.
33. 33. Spector, D. H.; Boss, B. D.; Strecker, R. E. A model three-dimensional culture system for mammalian dopaminergic precursor cells: Application for functional intracerebral transplantation. Exp. Neurol. 124:253-264; 1993.
34. 34. Spenger, C.; Hyman, C.; Studer, L.; Egli, M; Evtouchenko, L.; Jackson, C.; Dahl-Jørgensen, A.; Lindsay, R. M.; Seiler, R. W. Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon. Exp. Neurol. 133:50-63; 1995.
35. 35. Spenger, C.; Studer, L.; Evtouchenko, L.; Bühler, B.; Seiler, R. W. Human fetal ventral mesencephalic tissue cultures maintained in vitro for 7 to 14 days and transplanted to 6 OHDA lesioned rats give rise to grafts rich in dopaminergic neurons. Soc. Neurosci. Abstr. 21:2026; 1995.
36. 36. Spenger, C.; Studer, L.; Evtouchenko, L.; Egli, M.; Burgunder, J.-M.; Markwalder, R.; Seiler, R. W. Long-term survival of dopaminergic neurones in free-floating roller tube cultures of human fetal ventral mesencephalon. J. Neurosci. Methods 54:63-73; 1994.
37. 37. Strömberg, I.; van Horne, C.; Bygdeman, M.; Weiner, N.; Gerhardt, G. A. Function of intraventricular human mesencephalic xenografts in immunosuppressed rats: An electrophysiological and neurochemical analysis. Exp. Neurol. 112:140-152; 1991.
38. 38. Voorn, P.; Kalsbeek, A.; Jorritsma Byham, B.; Groenewegen, H. J. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25:857-887; 1988.
39. 39. Widner, H.; Tetrud, J.; Rehncrona, S.; Snow, B.; Brundin, P.; Gustavii, B.; Björklund, A.; Lindvall, O.; Langsten, J. W. Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327:1556-1563; 1992.
40. 40. Zhou, J.; Bradford, H. F.; Stern, G. M. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotorphic factor treatment. Brain Res. 656:147-156; 1994.